Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2014 17:12 ET | Source: Chimerix, Inc.

Chimerix to Present at the 16th Annual BIO CEO & Investor Conference

DURHAM, N.C., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that...
December 19, 2013 07:00 ET | Source: Chimerix, Inc.

Chimerix to Present at 32nd Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that...
December 18, 2013 07:00 ET | Source: Chimerix, Inc.

Chimerix Appoints Linda M. Richardson as Chief Commercial Officer

DURHAM, N.C., Dec. 18, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
December 17, 2013 07:00 ET | Source: Chimerix, Inc.

Chimerix Added to NASDAQ Biotechnology Index (NBI)

DURHAM, N.C., Dec. 17, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it...
November 26, 2013 17:00 ET | Source: Chimerix, Inc.

Chimerix to Present at 25th Annual Piper Jaffray Healthcare Conference

DURHAM, N.C., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that...
November 14, 2013 06:00 ET | Source: Chimerix, Inc.

Chimerix Announces Third Quarter 2013 Financial Results

DURHAM, N.C., Nov. 14, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported...
November 05, 2013 17:17 ET | Source: Chimerix, Inc.

Chimerix to Report Third Quarter Financial Results on November 14, 2013

DURHAM, N.C., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that it...
October 23, 2013 16:54 ET | Source: Chimerix, Inc.

Chimerix Announces Completion of Secondary Offering of Common Stock

DURHAM, N.C., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
October 18, 2013 09:25 ET | Source: Chimerix, Inc.

Chimerix Announces Pricing of Secondary Offering of Common Stock

DURHAM, N.C., Oct. 18, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
October 08, 2013 08:00 ET | Source: Chimerix, Inc.

Chimerix Announces Proposed Public Offering of Common Stock

DURHAM, N.C., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it...